290 related articles for article (PubMed ID: 35106737)
1. MicroRNA: Crucial modulator in purinergic signalling involved diseases.
Guo J; Yang P; Li YF; Tang JF; He ZX; Yu SG; Yin HY
Purinergic Signal; 2023 Mar; 19(1):329-341. PubMed ID: 35106737
[TBL] [Abstract][Full Text] [Related]
2. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
Yoshida K; Ito M; Matsuoka I
Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
[TBL] [Abstract][Full Text] [Related]
3. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-135a-5p reduces P2X
Reigada D; Calderón-García AÁ; Soto-Catalán M; Nieto-Díaz M; Muñoz-Galdeano T; Del Águila Á; Maza RM
J Neurochem; 2019 Oct; 151(1):116-130. PubMed ID: 30924927
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
6. Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells.
Adrian K; Bernhard MK; Breitinger HG; Ogilvie A
Biochim Biophys Acta; 2000 Jun; 1492(1):127-38. PubMed ID: 11004484
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of P2X1, P2X4 and P2X7 purinergic receptors in human monocyte-derived macrophages.
Vargas-Martínez EM; Gómez-Coronado KS; Espinosa-Luna R; Valdez-Morales EE; Barrios-García T; Barajas-Espinosa A; Ochoa-Cortes F; Montaño LM; Barajas-López C; Guerrero-Alba R
Eur J Pharmacol; 2020 Dec; 888():173460. PubMed ID: 32805257
[TBL] [Abstract][Full Text] [Related]
8. Human rheumatoid synoviocytes express functional P2X7 receptors.
Caporali F; Capecchi PL; Gamberucci A; Lazzerini PE; Pompella G; Natale M; Lorenzini S; Selvi E; Galeazzi M; Laghi Pasini F
J Mol Med (Berl); 2008 Aug; 86(8):937-49. PubMed ID: 18545980
[TBL] [Abstract][Full Text] [Related]
9. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6.
Roberts VH; Greenwood SL; Elliott AC; Sibley CP; Waters LH
Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1374-86. PubMed ID: 16373435
[TBL] [Abstract][Full Text] [Related]
10. Targeting the purinergic pathway in breast cancer and its therapeutic applications.
de Araújo JB; Kerkhoff VV; de Oliveira Maciel SFV; de Resende E Silva DT
Purinergic Signal; 2021 Jun; 17(2):179-200. PubMed ID: 33576905
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signaling: A gatekeeper of blood-brain barrier permeation.
Wang Y; Zhu Y; Wang J; Dong L; Liu S; Li S; Wu Q
Front Pharmacol; 2023; 14():1112758. PubMed ID: 36825149
[TBL] [Abstract][Full Text] [Related]
12. Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.
Wu XM; Zhang N; Li JS; Yang ZH; Huang XL; Yang XF
Purinergic Signal; 2023 Mar; 19(1):265-272. PubMed ID: 34981330
[TBL] [Abstract][Full Text] [Related]
13. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
14. Uncaria tomentosa extract alters the catabolism of adenine nucleotides and expression of ecto-5'-nucleotidase/CD73 and P2X7 and A1 receptors in the MDA-MB-231 cell line.
Santos KF; Gutierres JM; Pillat MM; Rissi VB; Santos Araújo MD; Bertol G; Gonçalves PB; Schetinger MR; Morsch VM
J Ethnopharmacol; 2016 Dec; 194():108-116. PubMed ID: 27590731
[TBL] [Abstract][Full Text] [Related]
15. P2X4 receptor as a modulator in the function of P2X receptor in CD4+ T cells from peripheral blood and adipose tissue.
Ruiz-Rodríguez VM; Cortes-García JD; de Jesús Briones-Espinoza M; Rodríguez-Varela E; Vega-Cárdenas M; Gómez-Otero A; García-Hernández MH; Portales-Pérez DP
Mol Immunol; 2019 Aug; 112():369-377. PubMed ID: 31279218
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
17. Extracellular ATP Induces Calcium Signaling in Odontoblasts.
Lee BM; Jo H; Park G; Kim YH; Park CK; Jung SJ; Chung G; Oh SB
J Dent Res; 2017 Feb; 96(2):200-207. PubMed ID: 27694154
[TBL] [Abstract][Full Text] [Related]
18. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
Volonté C; Amadio S
Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
[TBL] [Abstract][Full Text] [Related]
19. Ca2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells.
Gómez-Villafuertes R; del Puerto A; Díaz-Hernández M; Bustillo D; Díaz-Hernández JI; Huerta PG; Artalejo AR; Garrido JJ; Miras-Portugal MT
FEBS J; 2009 Sep; 276(18):5307-25. PubMed ID: 19682070
[TBL] [Abstract][Full Text] [Related]
20. Targeting purinergic receptors to attenuate inflammation of dry eye.
Wang JN; Fan H; Song JT
Purinergic Signal; 2023 Mar; 19(1):199-206. PubMed ID: 35218451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
